GSK, Vir requests emergency authorization from FDA for Covid antibody drug
In this photo illustration the British multinational pharmaceutical company GlaxoSmithKline (GSK) logo seen displayed on a smartphone with a computer model of the COVID-19 coronavirus on the background.
Budrul Chukrut | SOPA Images | Getty Images
Casual dining gets boost from pent up consumer demand, stimulus
CNBC’s Kate Rogers reports the rollout of Covid-19 vaccines and stimulus payments is giving a boost to the casual dining sector.
—Melodie Warner
Ambrosetti projects vaccinations in Italy will be complete ‘by mid-September’
Valerio de Molli, Managing Partner and CEO of the European House –Ambrosetti, said he’s optimistic Italy can complete the process of vaccinating 80% of its population by mid-September.
—Melodie Warner
India plans to widen vaccination campaign to include more people ‘in the near future’
A health worker administers a dose of COVID-19 vaccine at a clinic in Bhopal, India, March 25, 2021.
STR | Xinhua News Agency | Getty Images
India is planning to widen its coronavirus vaccination campaign to include more people, Health Minister Harsh Vardhan said Friday.
“The government is already planning to widen the umbrella of Covid-19 vaccine beneficiaries in the near future, to cover other sections of our population,” Vardhan said at a virtual conference.
Starting next month, people aged 45 and older will be eligible for the vaccination regardless of their health conditions.
India began the world’s largest mass vaccination campaign in January, with a target of initially inoculating some 300 million people including frontline workers.
— Saheli Roy Choudhury
Read CNBC’s previous live coverage here: